Quick Answer
Caris Life Sciences, Inc. reported Research And Development Expense of $101.58 million for the year ending 2025.
- Caris Life Sciences, Inc. showed a decrease of -10.8% in Research And Development Expense from 2024 to 2025.
- This data is from Caris Life Sciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 3, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2024: $24.79 million | Q3 2024: $27.64 million | Q2 2025: $25.05 million | Q3 2025: $21.62 million.
- Over the full 3 years of available data (2023 to 2025), Caris Life Sciences, Inc.'s Research And Development Expense has declined by 13.1%.
- Historical annual values: Fiscal year 2025: $101.58 million | Fiscal year 2024: $113.92 million | Fiscal year 2023: $116.88 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: